Evidence map›Paper›PMID 7971982›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Rabies ribonucleocapsid as an oral immunogen and immunological enhancer.

D C Hooper, I Pierard, A Modelska, L Otvos, Z F Fu, H Koprowski, B Dietzschold

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rabies virus nucleoprotein as a carrier for foreign antigens.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  10. Article
  11. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  12. Rabies superantigen as a Vbeta T-dependent adjuvant.The Journal of experimental medicine · 1996
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

D C HooperDepartment of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107-6799.
I Pierard
A Modelska
L Otvos
Z F Fu
H Koprowski
B Dietzschold
Thomas Jefferson University · US

Funding

RABIES VIRUS AND RABIES VIRUS ANTIGENSR01AI009706 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI KOPROWSKI, HILARY · 1996 to 2006
$2.4M
STUDY OF RABIES AND RABIES VIRUS ANTIGENSR22AI009706 · NIAID · WISTAR INSTITUTE · PI KOPROWSKI, HILARY · 1985 to 1985
–
STUDY OF RABIES AND RABIES VIRUS ANTIGENSR37AI009706 · NIAID · WISTAR INSTITUTE · PI KOPROWSKI, HILARY · 1986 to 1995
–
NIAID NIH HHS AI-09706
6 · The paper itself

Abstract

The administration of rabies ribonucleocapsid (RNP) by oral as well as parenteral routes was found to prime specific T cells and elicit N-protein-specific antibodies. per os and intramuscular immunization led to the production of antibodies of the IgA and IgG isotypes, respectively. Mice primed orally with RNP produced significantly enhanced amounts of virus-neutralizing antibody, compared with non-immune controls, upon subsequent parenteral booster immunization with inactivated rabies virus. Thus oral immunization with rabies RNP primed cells capable of mediating a secondary systemic response to rabies virus. The results of experiments in which peptide and protein antigens were administered either physically coupled to or mixed with RNP indicate that RNP has an inherent capacity to enhance immune responses.

Indexed as

Adjuvants, ImmunologicAdministration, OralAnimalsAntibodies, ViralAntigens, ViralCapsidFemaleImmunoglobulin ALymphocyte ActivationMiceMice, Inbred BALB CMice, Inbred C3HNeutralization TestsRabies virusT-LymphocytesVaccines, SyntheticAdjuvants, ImmunologicAntibodies, ViralAntigens, ViralImmunoglobulin AVaccines, SyntheticViral Core ProteinsViral Vaccines

Identifiers

PMID7971982
PMCPMC45135
OpenAlexW2135650995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.